Study to Evaluate Immunogenicity and Safety of TVAX-008 Injection in Non/Treated Chronic Hepatitis B Patients With HBsAg≤20IU/ml or HBsAg Negative Without Serological Conversion
Clinical trial NCT07204236 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07204236
- Sponsor
- Grand Theravac Life Sciences (Nanjing) Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-18
- Primary completion
- 2025-03-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.